This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hidmark, A. S. Articles by Karlsson Hedestam, G. B. Search for Related Content PubMed PubMed Citation Articles by Hidmark, A. S. Articles by Karlsson Hedestam, G. B.

Humoral Responses against Coimmunized Protein Antigen but Not against Alphavirus-Encoded Antigens Require Alpha/Beta Interferon Signaling

Åsa S. Hidmark, Eva K. L. Nordström, Pia Dosenovic, Mattias N. E. Forsell, Peter Liljeström, and Gunilla B. Karlsson Hedestam^*

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden, and Section of Vaccine Research, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden

Received 12 December 2005/ Accepted 24 April 2006

Viruses typically elicit potent adaptive immune responses, and live-virus-based vaccines are among the most efficient human vaccines known. The mechanisms by which viruses stimulate adaptive immune responses are not fully understood, but activation of innate immune signaling pathways in the early phase of the infection may be of importance. In addition to stimulating immune responses to viral antigens expressed in infected cells, viruses can also provide adjuvant signals to coimmunized protein antigens. Using recombinant Semliki Forest virus (rSFV)-based vaccines, we show that rSFV potently enhanced antibody responses against coimmunized protein antigens in the absence of other exogenously added adjuvants. Elicitation of antibody responses against both virus-encoded antigens and coimmunized protein antigens was independent of the signaling via Toll-like receptors (TLRs) previously implicated in antiviral responses. In contrast, the adjuvant effect of rSFV on coimmunized protein was completely abolished in mice lacking the alpha/beta interferon (IFN-/ß) receptor (IFN-AR1), demonstrating that IFN-/ß signaling was critical for mediating this effect. Antibody responses directed against virus-encoded antigens were intact in IFN-AR1^–/– mice, suggesting that other signals are sufficient to drive immune responses against virally encoded antigens. These data provide a basis for the adjuvant effect of rSFV and show that different signals are required to stimulate antibody responses to virally encoded antigens and to antigens administered as purified protein vaccines, together with viral particles.

Å.S.H. and E.K.L.N. contributed equally to this work.

This article has been cited by other articles:

• Ljungberg, K., Whitmore, A. C., Fluet, M. E., Moran, T. P., Shabman, R. S., Collier, M. L., Kraus, A. A., Thompson, J. M., Montefiori, D. C., Beard, C., Johnston, R. E. (2007). Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine. J. Virol. 81: 13412-13423 [Abstract] [Full Text]  
• Hutchings, C. L., Birkett, A. J., Moore, A. C., Hill, A. V. S. (2007). Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge. Infect. Immun. 75: 5819-5826 [Abstract] [Full Text]  
• Forsell, M. N. E., McInerney, G. M., Dosenovic, P., Hidmark, A. S., Eriksson, C., Liljestrom, P., Grundner, C., Karlsson Hedestam, G. B. (2007). Increased human immunodeficiency virus type 1 Env expression and antibody induction using an enhanced alphavirus vector. J. Gen. Virol. 88: 2774-2779 [Abstract] [Full Text]  
• Naslund, T. I., Uyttenhove, C., Nordstrom, E. K. L., Colau, D., Warnier, G., Jondal, M., Van den Eynde, B. J., Liljestrom, P. (2007). Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor. J. Immunol. 178: 6761-6769 [Abstract] [Full Text]  
• Douagi, I., McInerney, G. M., Hidmark, A. S., Miriallis, V., Johansen, K., Svensson, L., Karlsson Hedestam, G. B. (2007). Role of Interferon Regulatory Factor 3 in Type I Interferon Responses in Rotavirus-Infected Dendritic Cells and Fibroblasts. J. Virol. 81: 2758-2768 [Abstract] [Full Text]